NewsRx

Search our medical news database

Finance

Epigenomics AG reports 21% increase in 2005 revenues

Published in Health and Medicine Week, April 27th, 2006

Epigenomics AG (ECX), a molecular diagnostics company developing tests based on DNA methylation, reported its financial results for the fiscal year ending December 31, 2005.

Full year 2005 revenues were in line with guidance given during an annual press conference and analyst meeting in March, at EUR 9.6 million, an increase of 21% compared to FY 2004 of EUR 7.9 million. This was mainly due to successfully meeting the Roche program milestone in colon cancer screening and the strong performance of our SBU Clinical Solutions. The 2005 revenue base has been further broadened to include the new partners Qiagen and Philip Morris.

In 2005, Epigenomics...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook